Study of local anesthetic for caesarean section in pregnant females

A comparative study of Intrathecal hyperbaric 0.5 percent Levobupivacaine and hyperbaric 0.75 percent Ropivacaine for LSCS in preeclampsia Patients - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065731

Enrollment

Registered

2024-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O11- -2146826259 Health Condition 2: O149- Unspecified pre-eclampsia

Interventions

Intervention1: 0.75% Hyperbaric Ropivacaine: comparison between hyperbaric 0.5% levobupivacaine and hyperbaric 0.75% ropivacaine Control Intervention1: 0.5% hyperbaric levobupivacaine: comparison betw

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with pre-eclampsia undergoing LSCS

Exclusion criteria

Exclusion criteria: Eclampsia placenta previa contraindication of neuraxial block placental abruption pulmonary edema and cyanosis hepatic and renal involvement BMI more than 35 kg per meter square height less than 150 cm or more than 180 cm HELLP syndrome Multifetal pregnancy

Design outcomes

Primary

Measure	Time frame
hemodynamic parameter of hyperbaric 0.5% levobupivacaine during perioperative periodTimepoint: 12 months	—

Secondary

Measure	Time frame
onset of sensory block and motor block duration of analgesia quality of motor blockadeTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Rampaukuheibe Hau

Institute of Medical Sciences, Banaras Hindu University

minearvind@gmail.com9717966333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026